-
Application of calprotenin combined with fecal occult blood test in colorectal cancer screening
Colorectal cancer is one of the most common malignant tumors and its incidence is increasing year by year. Early detection of colorectal cancer is crucial for treatment and prognosis, so screening has become one of the important means to prevent colorectal cancer. At present, the commonly used colorectal cancer screening methods include colonoscopy, stool occult blood test and so on.
01-07-2024 -
Bowel cancer three-way test: Early screening saves lives
Colorectal cancer is one of the most common malignant tumors of the digestive system worldwide, and early diagnosis and treatment are essential to improve the survival rate of patients.
21-06-2024 -
POCT solution for primary medical care
With the continuous development and progress of medical technology, POCT has become an important solution to solve primary medical problems. By moving medical detection to the patient's side, POCT technology realizes rapid and accurate diagnosis and provides a more convenient and efficient solution for primary care.
26-04-2024 -
SEACare 2024 comes to a successful conclusion
On April 19, the 24th Malaysia Medical Devices & Rehabilitation Healthcare Exhibition 2024 was successfully held at the Kuala Lumpur Convention Centre.
19-04-2024 -
Calprotectin combined with fecal occult blood screening for colorectal cancer
The combined use of calprotectin and fecal occult blood screening for colorectal cancer has drawn a significant attention in recent years as a screening project. It is primarily used to detect early-stage colorectal cancer and polyps, in order to increase the chances of successful treatment.
22-03-2024 -
Wizbiotech's 1 product registration is certified!
Warm congratulations, a product of Wizbiotech has been approved by MDA, the Malaysian medical device regulatory agency.
07-02-2024